Has Jose Munoz Acaba, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,372 in general payments to Jose Munoz Acaba, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jose Munoz Acaba, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jose Munoz Acaba, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jose Munoz Acaba, MD

Gastroenterology · San Juan, PRNPI 1295984375

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.7%), consulting fees and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Sanofi at 44.7% of the total. Reporting peaked in 2023 at $2,254 and has fallen 76.9% since, to $520 in 2025.

$4,372in general payments, 2019–2025

Across 53 payments — averaging $82.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$2K
AbbVie$1K
E.r. Squibb & Sons, L.L.C.$346
Johnson & Johnson$267
Gilead$135
Takeda Pharmaceuticals U.S.A., Inc.$120
plus $190 from 3 others

$24,000in research payments, 2019–2025

Across 1 payment — averaging $24,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$24K

What the payments were for

Consulting fees$1,66538%
Food & beverage$2,60860%
Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	3	$1,954
AbbVie	27	$1,360
E.r. Squibb & Sons, L.L.C.	8	$346
Johnson & Johnson(2 entities)	8	$267
Gilead	1	$135
Takeda Pharmaceuticals U.S.A., Inc.	1	$120
Merck	1	$98
Exact Sciences	2	$50
PBG Puerto Rico LLC	2	$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$1,815
Mavyret$433
Rinvoq$249
Skyrizi$249
ELIQUIS$236
Epclusa$135
Entyvio$120

How this compares

$4,372 in reported general payments places this provider in the 75th percentile of 198 gastroenterology providers in Puerto Rico.

See all gastroenterology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024

$41,149

Medicare patients

105

Services billed

314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sucralfate	427	$61,281
XifaxanRifaximin	13	$36,061
Dexlansoprazole DrDexlansoprazole	127	$28,476
SuprepSodium, Potassium,mag Sulfates	168	$19,781
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	180	$14,091
Mesalamine	30	$12,171
Lubiprostone	86	$11,477
Cholestyramine LightCholestyramine	59	$7,854
Famotidine	675	$5,827
Pantoprazole Sodium	532	$4,605
Ursodiol	33	$2,755
Clarithromycin	38	$1,985
Lansoprazole	126	$1,900
Ondansetron OdtOndansetron	91	$1,330
Dicyclomine Hcl	121	$1,312

Paid to pharmacies, not to this prescriber.

Other gastroenterology in San Juan

Marcia Cruz CorreaSan Juan$62K
Loscar SantiagoSan Juan$39K
Henry Gonzalez RiveraSan Juan$34K
Hector LozanoSan Juan$28K
Rafael Rodriguez LopezSan Juan$20K
Alexis Gonzalez RiveraSan Juan$16K
Sulimar Rodriguez SantiagoSan Juan$11K
Esther TorresSan Juan$9K
Yahaira Moreno DenizardSan Juan$9K
Ricky Jimenez CarloSan Juan$8K

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →